Sign in to view content

Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results

Dilraj S Grewal, MD, FASRS

Video
Published 2023

Related

Does the Diabetic Status Influence the Rate of Cataract Surgery Following Pars Plana Vitrectomy Surgery?
Ahmed Sallam, MD PhD FRCOphth
On Demand Cases, Courses, and Papers
2019
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Hani Salehi-Had, MD, FASRS
Annual Meeting Talks
2023
Future Direction of the DRCR Retina Network
Daniel F. Martin, MD
Updates from the Field
2019

Category: Socioeconomics

See more